Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Chemours Company (The) Common Stock (NY:CC)

14.98 +0.03 (+0.20%)
Streaming Delayed Price Updated: 12:01 PM EDT, Aug 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Chemours Company (The) Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
19 20 Next >
Analyst Finds It Difficult To Make Numeric Assumptions For Chemours: Here's Why
BMO analyst downgrades Chemours to Underperform, citing delayed filings, management changes, and difficulty in making earnings assumptions. 
Via Benzinga
Bragar Eagel & Squire, P.C. Is Investigating Chemours, Methanex, and AirSculpt and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Lost Money in the Chemours Company? Gibbs Law Group Investigates Potential Securities Law Violations
From Gibbs Law Group
Via Business Wire
Why Chemours Stock Crashed 37% This Morning
Everything that could have gone wrong for Chemours stock today did go wrong. 
Via The Motley Fool
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation - CC
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation - CC
WHY: NEW YORK, NY - (NewMediaWire) - February 29, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The... 
Via TheNewswire.com
The Law Offices of Frank R. Cruz Continues Investigation of The Chemours Company (CC) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Chemours (NYSE: CC): Kaplan Fox Investigates Potential Securities Fraud at Chemours - Company Executives Placed on Administrative Leave
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud
Chemours (NYSE: CC): Kaplan Fox Investigates Potential Securities Fraud at Chemours - Company Executives Placed on Administrative Leave
NEW YORK, NY - (NewMediaWire) - February 29, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”)... 
Via TheNewswire.com
Topics Fraud
Wall Street Takes A Breather As Inflation Stays Tamed, AMD Hits Record Highs, Apple Struggles: What's Driving Markets Thursday?
Wall Street exhaled a sigh of relief as the Federal Reserve’s favored gauge of inflation cooled as anticipated in January, quelling fears that an unexpected rise in the Consumer Price Index (CPI) might... 
Via Benzinga
Topics Economy
Berman Tabacco Announces Investigation of The Chemours Company (CC) for Potential Securities Law Violations
From Berman Tabacco
Via GlobeNewswire
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. 
Via Benzinga
Nasdaq Gains 100 Points Following PCE Data
U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 100 points on Thursday. Following the market opening Thursday, the Dow traded down 0.07% to 38,923.11 while the... 
Via Benzinga
Topics Stocks
Chemours Stock Tumbles As Company Reveals Management Shakeup And Financial Struggles
Chemours Company reports prelim results, management changes, and delay in 10-K form. Net sales down, net loss expected. 
Via Benzinga
Why Is Ironwood Pharmaceuticals (IRWD) Stock Down 27% Today?
Ironwood Pharmaceuticals stock is falling on Thursday with investors in IRWD unimpressed by its latest Phase III clinical trial results. 
Via InvestorPlace
Why Is Chemours (CC) Stock Down 36% Today?
Chemours stock is falling on Thursday as CC investors react to management changes going into effect due to an internal review. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the news affecting shares this morning! 
Via InvestorPlace
Shoals Technologies Posts Weak Q4 Results, Joins Butterfly Network, Schrödinger And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures trading lower by over 100 points on Thursday. 
Via Benzinga
Topics Stocks
CORRECTING and REPLACING Chemours Announces Management Actions and Delay of Form 10-K; Provides Preliminary Unaudited 2023 Year-End Results
From The Chemours Company
Via Business Wire
CC INVESTOR NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation - CC
WHY: NEW YORK, NY - (NewMediaWire) - February 27, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The... 
Via NewMediaWire
CC INVESTOR NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation - CC
WHY: NEW YORK, NY - (NewMediaWire) - February 27, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The... 
Via TheNewswire.com
The Chemours Company (CC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation – CC
From The Rosen Law Firm PA
Via GlobeNewswire
Kirby McInerney LLP is Investigating Potential Shareholder Claims Against The Chemours Company (CC)
From Kirby McInerney LLP
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Waldencast, and Chemours and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation - CC
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation - CC
WHY: NEW YORK, NY - (NewMediaWire) - February 20, 2024 - Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of The... 
Via TheNewswire.com
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation – CC
From The Rosen Law Firm PA
Via GlobeNewswire
Chemours Announces Changes to its Board of Directors
From The Chemours Company
Via Business Wire
CHEMOURS ALERT: Bragar Eagel & Squire, P.C. is Investigating The Chemours Company on Behalf of Chemours Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.